Filing Details

Accession Number:
0001140361-13-022194
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-22 10:30:01
Reporting Period:
2013-05-20
Filing Date:
2013-05-22
Accepted Time:
2013-05-22 10:30:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
864683 Cyberonics Inc CYBX Electromedical & Electrotherapeutic Apparatus (3845) 760236465
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1454309 Mayo Milton Morris 100 Cyberonics Blvd
Houston TX 77058
Sr Vp Research & Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-20 5,000 $16.38 58,009 No 4 M Direct
Common Stock Disposition 2013-05-20 5,000 $49.19 53,009 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to purchase common stock Acquisiton 2013-05-20 5,000 $16.38 5,000 $16.38
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
75,312 2019-01-16 No 4 M Direct
Footnotes
  1. Shares sold pursuant to a Rule 10b5-1 Plan.
  2. Represents weighted average selling price. Securities were sold through approximately 22 separate sales on the transaction date at prices ranging from $48.8650 to $49.3066. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer, the full information regarding the number of shares and prices at which the transaction was effected.
  3. Reporting Person was granted an option to purchase 45,000 shares of common stock on January 16, 2009. The option is fully vested and expires January 16, 2019. The option was subject to certain vesting and forfeiture requirements in accordance with the terms of the applicable Stock Option Agreement.